Even though EGFR, KRAS, and BRAF gene mutations are the most characteristic in lung cancer patients, TP53 gene mutations are frequently detected as well, even in cases where no mutations are found in the EGFR, KRAS, and BRAF genes. This evidence concerns the gene EGFR and lung carcinoma.